Investment
Features
FeesSafety
Academy
More
Pluang+

Armata Pharmaceuticals secures patents for key bacteriophage therapies through 2041, advancing antibiotic-resistant infection treatments.

Company Fundamentals
07 Oct 2026
PRNewsWire
View Source
Bullish
Armata Pharmaceuticals secures patents for key bacteriophage therapies through 2041, advancing antibiotic-resistant infection treatments.

Armata Pharmaceuticals announced the issuance of two U.S. patents protecting its bacteriophage therapy candidates AP-SA02 and AP-PA02 until at least 2041. These patents strengthen Armata's intellectual property in developing treatments for antibiotic-resistant infections caused by Staphylococcus aureus and Pseudomonas aeruginosa. AP-SA02 is preparing for a Phase 3 superiority study later in 2026, targeting complicated Staphylococcus aureus bacteremia, while AP-PA02 is in development for chronic respiratory infections. This patent protection supports Armata's leadership in phage therapeutics and underpins its long-term strategy in combating difficult-to-treat bacterial infections.

Armata Pharmaceuticals' recent patent issuances provide context for readers interested in health sector developments. For readers following health-sector stocks on Pluang, here is the market snapshot as of Oct 07, 2026 16:51 WIB: out of 100 priced US health stocks, 52 rose and 40 fell. Notable movers include AMWL at USD 12.71 with a 1-day change of +3.59% and 100% sell order activity, RXRX at USD 4.48 down 3.24% with 79% sell orders, and BAX at USD 23.70 down 2.71% but with 100% buy order activity.

More News

Chainlink price dips nearly 5% amid cooling momentum despite new institutional products launch.

Chainlink price dips nearly 5% amid cooling momentum despite new institutional products launch.

Chainlink's price fell about 4.74% to around $13.35, with a weekly loss of over 7%, as traders reacted to cooling momentum despite the launch of new institutional products like CCIP 2.0 and Fulcrum. While the token saw a roughly 24% price increase in...

Technical Signals
Neutral
4 hours ago
Genius Group buys 10 BTC for $854K, restarting Bitcoin treasury plan targeting $827M by 2031

Genius Group buys 10 BTC for $854K, restarting Bitcoin treasury plan targeting $827M by 2031

Genius Group has resumed buying Bitcoin, acquiring 10 BTC for about $854,000 between October 2 and 5 at an average price of $85,364 per BTC. This purchase is part of the company's broader $1.2 billion dual-treasury strategy aiming for $827 million in...

Protocol Fundamentals
Bullish
4 hours ago
Solana's active programs hit a record 8,400 in September, boosting developer activity and app revenue.

Solana's active programs hit a record 8,400 in September, boosting developer activity and app revenue.

In September, Solana's monthly active programs surpassed 8,400, marking a new record for the blockchain's developer activity. Funded wallets increased by 38.5% to 16.1 million, and daily active stablecoin addresses grew 269% year-over-year to 888,000...

Protocol Fundamentals
Bullish
4 hours ago
Commodities and stocks drive strong gains in global portfolios this year, with commodities leading.

Commodities and stocks drive strong gains in global portfolios this year, with commodities leading.

This year, the main contributors to strong gains in globally diversified portfolios are commodities and stocks. Commodities have outperformed by a wide margin, while U.S. equities and developed market stocks outside the U.S. each gained about 15%. Th...

Market News
Bullish
4 hours ago
SAP Pay integrates Circle's USDC and EURC stablecoins for enterprise payments within SAP Cloud ERP

SAP Pay integrates Circle's USDC and EURC stablecoins for enterprise payments within SAP Cloud ERP

SAP Pay, a new payment service launched by Tereina and backed by SAP, now supports Circle's USDC and EURC stablecoins for enterprise payment workflows within SAP Cloud ERP. This integration allows businesses to pay suppliers using stablecoins alongsi...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App